Common Variant rs9939609 in Gene FTO Confers Risk to Polycystic Ovary Syndrome

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Li, Tao ^a,b   Wu, Keliang ^a,b,c,d   You, Li ^a,b,c,d   Xing, Xiuye ^a,b   Wang, Peng ^a,b   Cui, Linlin ^a,b   Liu, Hongbin ^a,b,c,d   Cui, Yuqian ^e   Bian, Yuehong ^a,b,c,d   Ning, Yunna ^a,b,c,d   Zhao, Han ^a,b,c,d   Tang, Rong ^a,b   Chen, Zi Jiang ^a,b,c,d,e  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^b NATIONAL RESEARCH CENTER FOR ASSISTED REPRODUCTIVE TECHNOLOGY AND REPRODUCTIVE GENETICS   (China)

^c BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^d Shandong Provincial Key Laboratory of Reproductive Medicine   (China)

^e SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BODY MASS; CHINESE; CONTROLLED STUDY; FEMALE; FTO GENE; GENE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; OBESITY; OVARY POLYCYSTIC DISEASE; REPLICATION STUDY; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BODY MASS INDEX; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; OBESITY; POLYCYSTIC OVARY SYNDROME; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEINS; YOUNG ADULT;

EID: 84879707663     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0066250     Document Type: Article

References (45)

1. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, et al. (2004) The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 89: 2745-2749.
2. Balen AH, Conway GS, Kaltsas G, Techatrasak K, Manning PJ, et al. (1995) Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients. Hum Reprod 10: 2107-2111.
3. Carmina E, Azziz R, (2006) Diagnosis, phenotype, and prevalence of polycystic ovary syndrome. Fertil Steril 86Suppl 1: S7-8.
4. Lim SS, Davies MJ, Norman RJ, Moran LJ, (2012) Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update 18: 618-637.
5. Shi Y, Guo M, Yan J, Sun W, Zhang X, et al. (2007) Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome. Neuro Endocrinol Lett 28: 807-810.
6. Azziz R, Sanchez LA, Knochenhauer ES, Moran C, Lazenby J, et al. (2004) Androgen excess in women: experience with over 1000 consecutive patients. J Clin Endocrinol Metab 89: 453-462.
7. Barber TM, McCarthy MI, Wass JA, Franks S, (2006) Obesity and polycystic ovary syndrome. Clin Endocrinol (Oxf) 65: 137-145.
8. Lim SS, Norman RJ, Davies MJ, Moran LJ, (2013) The effect of obesity on polycystic ovary syndrome: a systematic review and meta-analysis. Obes Rev 14: 95-109.
9. Amato P, Simpson JL, (2004) The genetics of polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol 18: 707-718.
10. Vink JM, Sadrzadeh S, Lambalk CB, Boomsma DI, (2006) Heritability of polycystic ovary syndrome in a Dutch twin-family study. J Clin Endocrinol Metab 91: 2100-2104.
11. Walley AJ, Blakemore AI, Froguel P, (2006) Genetics of obesity and the prediction of risk for health. Hum Mol Genet 15 Spec No 2: R124-130.
12. Stratigopoulos G, Padilla SL, LeDuc CA, Watson E, Hattersley AT, et al. (2008) Regulation of Fto/Ftm gene expression in mice and humans. Am J Physiol Regul Integr Comp Physiol 294: R1185-1196.
13. Chang YC, Liu PH, Lee WJ, Chang TJ, Jiang YD, et al. (2008) Common variation in the fat mass and obesity-associated (FTO) gene confers risk of obesity and modulates BMI in the Chinese population. Diabetes 57: 2245-2252.
14. Peng S, Zhu Y, Xu F, Ren X, Li X, et al. (2011) FTO gene polymorphisms and obesity risk: a meta-analysis. BMC Med 9: 71.
15. Dina C, Meyre D, Gallina S, Durand E, Korner A, et al. (2007) Variation in FTO contributes to childhood obesity and severe adult obesity. Nat Genet 39: 724-726.
16. Scuteri A, Sanna S, Chen WM, Uda M, Albai G, et al. (2007) Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits. PLoS Genet 3: e115.
17. Walley AJ, Asher JE, Froguel P, (2009) The genetic contribution to non-syndromic human obesity. Nat Rev Genet 10: 431-442.
18. Wen W, Cho YS, Zheng W, Dorajoo R, Kato N, et al. (2012) Meta-analysis identifies common variants associated with body mass index in east Asians. Nat Genet 44: 307-311.
19. Frayling TM, Timpson NJ, Weedon MN, Zeggini E, Freathy RM, et al. (2007) A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 316: 889-894.
20. Scott LJ, Mohlke KL, Bonnycastle LL, Willer CJ, Li Y, et al. (2007) A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 316: 1341-1345.
21. Hertel JK, Johansson S, Sonestedt E, Jonsson A, Lie RT, et al. (2011) FTO, type 2 diabetes, and weight gain throughout adult life: a meta-analysis of 41,504 subjects from the Scandinavian HUNT, MDC, and MPP studies. Diabetes 60: 1637-1644.
22. Li H, Kilpelainen TO, Liu C, Zhu J, Liu Y, et al. (2012) Association of genetic variation in FTO with risk of obesity and type 2 diabetes with data from 96,551 East and South Asians. Diabetologia 55: 981-995.
23. Barber TM, Bennett AJ, Groves CJ, Sovio U, Ruokonen A, et al. (2008) Association of variants in the fat mass and obesity associated (FTO) gene with polycystic ovary syndrome. Diabetologia 51: 1153-1158.
24. Ewens KG, Jones MR, Ankener W, Stewart DR, Urbanek M, et al. (2011) FTO and MC4R gene variants are associated with obesity in polycystic ovary syndrome. PLoS One 6: e16390.
25. Saxena R, Welt CK (2012) Polycystic ovary syndrome is not associated with genetic variants that mark risk of type 2 diabetes. Acta Diabetol.
26. Yan Q, Hong J, Gu W, Zhang Y, Liu Q, et al. (2009) Association of the common rs9939609 variant of FTO gene with polycystic ovary syndrome in Chinese women. Endocrine 36: 377-382.
27. Chen ZJ, Zhao H, He L, Shi Y, Qin Y, et al. (2011) Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3. Nat Genet 43: 55-59.
28. Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19: 41-47.
29. Weisell RC, (2002) Body mass index as an indicator of obesity. Asia Pac J Clin Nutr 11Suppl 8: S681-684.
30. Purcell S, Cherny SS, Sham PC, (2003) Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 19: 149-150.
31. Shi Y, Zhao H, Cao Y, Yang D, Li Z, et al. (2012) Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome. Nat Genet 44: 1020-1025.
32. Berulava T, Horsthemke B, (2010) The obesity-associated SNPs in intron 1 of the FTO gene affect primary transcript levels. Eur J Hum Genet 18: 1054-1056.
33. Grunnet LG, Nilsson E, Ling C, Hansen T, Pedersen O, et al. (2009) Regulation and function of FTO mRNA expression in human skeletal muscle and subcutaneous adipose tissue. Diabetes 58: 2402-2408.
34. Wahlen K, Sjolin E, Hoffstedt J, (2008) The common rs9939609 gene variant of the fat mass- and obesity-associated gene FTO is related to fat cell lipolysis. J Lipid Res 49: 607-611.
35. Velders FP, De Wit JE, Jansen PW, Jaddoe VW, Hofman A, et al. (2012) FTO at rs9939609, food responsiveness, emotional control and symptoms of ADHD in preschool children. PLoS One 7: e49131.
36. Kim JJ, Choi YM, Cho YM, Hong MA, Chae SJ, et al. (2012) Polycystic ovary syndrome is not associated with polymorphisms of the TCF7L2, CDKAL1, HHEX, KCNJ11, FTO and SLC30A8 genes. Clin Endocrinol (Oxf).
37. Attaoua R, Ait El Mkadem S, Radian S, Fica S, Hanzu F, et al. (2008) FTO gene associates to metabolic syndrome in women with polycystic ovary syndrome. Biochem Biophys Res Commun 373: 230-234.
38. Olszewski PK, Radomska KJ, Ghimire K, Klockars A, Ingman C, et al. (2011) Fto immunoreactivity is widespread in the rodent brain and abundant in feeding-related sites, but the number of Fto-positive cells is not affected by changes in energy balance. Physiol Behav 103: 248-253.
39. Wu Q, Saunders RA, Szkudlarek-Mikho M, Serna Ide L, Chin KV, (2010) The obesity-associated Fto gene is a transcriptional coactivator. Biochem Biophys Res Commun 401: 390-395.
40. Gerken T, Girard CA, Tung YC, Webby CJ, Saudek V, et al. (2007) The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase. Science 318: 1469-1472.
41. Qu F, Wang FF, Yin R, Ding GL, El-Prince M, et al. (2012) A molecular mechanism underlying ovarian dysfunction of polycystic ovary syndrome: hyperandrogenism induces epigenetic alterations in the granulosa cells. J Mol Med (Berl) 90: 911-923.
42. Tan S, Scherag A, Janssen OE, Hahn S, Lahner H, et al. (2010) Large effects on body mass index and insulin resistance of fat mass and obesity associated gene (FTO) variants in patients with polycystic ovary syndrome (PCOS). BMC Med Genet 11: 12.
43. Wojciechowski P, Lipowska A, Rys P, Ewens KG, Franks S, et al. (2012) Impact of FTO genotypes on BMI and weight in polycystic ovary syndrome: a systematic review and meta-analysis. Diabetologia.
44. Wehr E, Schweighofer N, Moller R, Giuliani A, Pieber TR, et al. (2010) Association of FTO gene with hyperandrogenemia and metabolic parameters in women with polycystic ovary syndrome. Metabolism 59: 575-580.
45. Hatziagelaki E, Wagner R, Kantartzis K, Heni M, Linder K, et al. (2012) Insulin Resistant Phenotype of Polycystic Ovary Syndrome does not Seem to be Caused by Variation in FTO. Horm Metab Res.